W746C (p.Trp746Cys) variant of GAA (Lysosomal alpha-glucosidase)
W746C (p.Trp746Cys) in GAA (Lysosomal alpha-glucosidase) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Glycogen storage disease, type II. The available variant effect predictions contribute to a CATVariant prioritization score of 0.87 / 1. The record also includes population frequency data, published literature, and structural context.
W746C (p.Trp746Cys) variant details
- p.Trp746Cys
- rs1800312
- ClinGen CA8815665
- ClinVar RCV000254988
- ClinVar RCV000283919
- Likely pathogenic
- Glycogen storage disease, type II
- Missense
- Variant Prioritization Score for Impact Estimate 0.867
- REVEL 0.90
- CADD 32.00
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Likely pathogenic (Glycogen storage disease, type II)
- EBI: Pathogenic (in IOPD and LOPD)
- UniProt: Pathogenic (in IOPD and LOPD)
- Most common in the 1KG:CLM population (allele frequency 0.0053)
- Structural context available
- Cited in: Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. (PMID 16917947)
- Cited in: Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. (PMID 20080426)